BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 30287168)

  • 1. Systemic chemotherapy in combination with liver-directed therapy improves survival in patients with pancreatic adenocarcinoma and synchronous liver metastases.
    Ouyang H; Ma W; Zhang T; Liu F; Zhao L; Fang M; Quan M; Pan Z
    Pancreatology; 2018 Dec; 18(8):983-989. PubMed ID: 30287168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for Liver Metastases From Pancreatic Cancer: A Propensity Score Matching Analysis.
    Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
    Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing survival of patients with pancreatic adenocarcinoma and synchronous liver metastases receiving palliative care.
    Ouyang H; Ma W; Liu F; Yue Z; Fang M; Quan M; Pan Z
    Pancreatology; 2017; 17(5):773-781. PubMed ID: 28734721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial infusion plus systemic chemotherapy as third-line or later treatment in colorectal liver metastases.
    Qiang WG; Shi LR; Li XD; Wu QQ; Zhao JM; Chen LJ; Yang Y; Wu J; Ji M; Wu CP
    Clin Transl Oncol; 2015 Nov; 17(11):870-5. PubMed ID: 26055340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multidisciplinary treatment and survival analysis for 497 cases of pancreatic cancer with liver metastases].
    Ouyang HH; Pan ZY; Ma WD; Zhao LJ; Zhang T; Liu F; Quan MM
    Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(6):425-30. PubMed ID: 26875916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic analysis of 220 colorectal cancer patients with synchronous liver metastases].
    He YF; Li YH; Zhang DS; Xiang XJ; Xu RH; Pan ZZ; Zhou ZW; Jiang WQ; He YJ; Wan DS
    Ai Zheng; 2006 Sep; 25(9):1153-7. PubMed ID: 16965661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Liver-Directed Therapy and Systemic Therapy for the Treatment of Liver Metastases in Patients with Gastrointestinal Neuroendocrine Tumors: Analysis of the California Cancer Registry.
    Kessler J; Singh G; Ituarte PHG; Allen R; Chang S; Li D
    J Vasc Interv Radiol; 2021 Mar; 32(3):393-402. PubMed ID: 33358144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
    Kemeny N; Huang Y; Cohen AM; Shi W; Conti JA; Brennan MF; Bertino JR; Turnbull AD; Sullivan D; Stockman J; Blumgart LH; Fong Y
    N Engl J Med; 1999 Dec; 341(27):2039-48. PubMed ID: 10615075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of liver-directed therapy in colorectal cancer liver metastases.
    Vargas GM; Parmar AD; Sheffield KM; Tamirisa NP; Brown KM; Riall TS
    J Surg Res; 2014 Sep; 191(1):42-50. PubMed ID: 24990539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
    Andreou A; Knitter S; Klein F; Malinka T; Schmelzle M; Struecker B; Schmuck RB; Noltsch AR; Lee D; Pelzer U; Denecke T; Pratschke J; Bahra M
    Surg Oncol; 2018 Dec; 27(4):688-694. PubMed ID: 30449494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma.
    Gibbs P; Do C; Lipton L; Cade DN; Tapner MJ; Price D; Bower GD; Dowling R; Lichtenstein M; van Hazel GA
    BMC Cancer; 2015 Oct; 15():802. PubMed ID: 26503593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
    Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report.
    Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S
    J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features and treatment strategies for patients with pancreatic adenocarcinoma and ovarian metastases.
    Falchook GS; Wolff RA; Varadhachary GR
    Gynecol Oncol; 2008 Mar; 108(3):515-9. PubMed ID: 18164378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific treatment situations in metastatic colorectal cancer].
    Arnold D; Schmoll HJ; Lang H; Knoefel WT; Ridwelski K; Trarbach T; Staib L; Kirchner T; Geissler M; Seufferlein T; Amthauer H; Riess H; Schlitt HJ; Piso P
    Onkologie; 2010; 33 Suppl 4():8-18. PubMed ID: 20431307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of inoperable liver metastases from colorectal cancer].
    Milandri C; Calzolari F; Giampalma E; Vagliasindi A; Bertagni A; Ridolfi L; Passardi A; Ridolfi R; Golfieri R; Verdecchia GM
    Tumori; 2003; 89(4 Suppl):112-4. PubMed ID: 12903565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is lung involvement a favorable prognostic factor for pancreatic ductal adenocarcinoma with synchronous liver metastases?-A propensity score analysis.
    Ouyang H; Ma W; Jiang X; Gerdtsson AS; Liu D; Pan Z
    Expert Rev Gastroenterol Hepatol; 2023 Apr; 17(4):405-412. PubMed ID: 36803208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA.
    DeWitt J; Yu M; Al-Haddad MA; Sherman S; McHenry L; Leblanc JK
    Gastrointest Endosc; 2010 Feb; 71(2):260-5. PubMed ID: 19922924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chemotherapy as a main strategy for liver metastases from gastric cancer.
    Zhang W; Yu Y; Fang Y; Wang Y; Cui Y; Shen K; Liu T
    Clin Transl Oncol; 2015 Nov; 17(11):888-94. PubMed ID: 26108406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.